COVID-19 vaccine development followed the same safety guidelines as other vaccines we normally get. Tens of thousands of people participated in clinical trials for the vaccines. Adults of all ages and races were included. People with diabetes, asthma, heart disease and other health conditions were included. The testing found the vaccines to be safe among all groups included in the trials. Now, millions of people have safely received the vaccine since the trials ended.